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CHAPTER 1: INTRODUCTION 
The cardiovascular system is an intricate mechanism that provides the body with nutrients 
and a means of gas exchange with the tissues and organelles. The heart is the organ 
responsible for pumping the blood throughout the body and providing pulmonary circulation 
for gas exchange in the lungs. The cardiovascular system is one of many systems in the body 
controlled by the Autonomic Nervous System (ANS). The latter is responsible for providing 
signals that cause either an increase in the heart rate, via increased sympathetic nervous 
system (SNS) activity, or a decrease by way of either an increase in parasympathetic nervous 
system (PNS) activity or a decrease in SNS activity. 
The SNS and PNS regulate the heart rate with the use ofbaroreceptors that are 
located in the aortic arch, the carotid arteries and the heart. When the blood pressure in 
these receptor areas is low, there is a signal sent to the medulla oblongata (the portion of 
the brain responsible for autonomic function) which inhibits PNS activity to reduce vagal 
tone and stimulates the SNS to release epinephrine and norepinephrine (Sander-Jensen, 
Mehlsen, Stadeager, Christensen, Fahrenkrug, Schwartz, Warberg, and Bie, 1988). These 
catecholamines cause the heart rate to accelerate and elicit vasoconstriction thereby 
elevating blood pressure. If the blood pressure is elevated too much, the baroreceptors 
increase the amount of action potentials sent to the medulla; the SNS is inhibited and the 
PNS is stimulated, causing the release of acetylcholine (Ach) from the vagus nerve 
(Sander-Jensen et al., 1988). Peripheral vasodilation and a decline in heart rate result. 
Heart rate variability (HRV) refers to the beat-to-beat temporal fluctuations that the 
heart undergoes. These occur because of the fluctuations in the neural outflow of the 
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SNS and the PNS. This beat-to-beat variability is difficult to determine by common 
measures such as measuring heart rate. Spectral analysis ofHRV is a useful tool to assess 
the modulation of heart rate by PNS and SNS. It is begun by reducing the heart rate time 
signal into a frequency component and quantifying its relative power (Lipsitz, Mietus, 
Moody, and Goldberger, 1990). Spectral analysis uses frequencies between Oto ~0 .4 Hz 
to assess the autonomic nervous system modulation of the cardiovascular system. A 
frequency component of0.04 to 0.15 Hz reflects the effects of SNS activity; this is termed 
low frequency (LF). High frequency (HF) is found to be from 0.15 to 0.4 Hz and implies 
the presence of increased PNS activity. 
For centuries, researchers have been trying to develop a better understanding of how 
the cardiovascular system is controlled. There is a link between the control of heart rate 
and the body's ability to resist a sudden change in the velocity of the body (Halliwill, 
Lawler, Eickoff, Joyner, and Mulvagh, 1998). For example, when a jet pilot pulls up from 
a dive, blood pools into the legs causing a decrease in the amount of blood circulating in 
the upper torso. This reduced cerebral blood flow causes a feeling of dizziness for a few 
moments until the cardiovascular system responds. The resultant increase in heart rate 
and peripheral constriction causes blood flow to the brain to normalize. 
Older people, hypotensive populations and people with various cardiac diseases often 
experience this feeling of dizziness (presyncope) during orthostatic stress (Luutonen, 
Antila, Neuvonen, Raiha, Rajala, and Sourander, 1994). Astronauts also experience this 
feeling of near-syncope after prolonged exposure to microgravity (Verbanck, Larsson, 
Linnarsson, Prisk, West, and Paiva, 1997). This phenomenon is also seen in subjects 
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exposed to bed-rest for a lengthy period of time (Halliwill et al., 1998). Bed-rest can 
- . 
cause the baroreflex centers to become less reactive to an orthostatic stress (Halliwill et 
al., 1998). The population most susceptible to orthostatic intolerance is elderly people. 
who are placed on bed rest because of a past ailment (Luutonen et al., 1994). 
Lower body negative pressure testing has been used to determine the status of 
baroreceptor reflex function, assess the cardiovascular response to orthostatic stress, and 
assess tolerance. However, relatively few studies have involved the use of the lower body 
negative pressure with concurrent spectral reading of the heart. In order to use any of the 
' . 
heart rate variability indices for clinical purposes, the values must be shown to be 
reproducible. Repeatable results using spectral analysis ofHRV anq. the table-tilt test as 
an orthostatic stress have been found (Kockiadakis, Kanoupakis, Rombola, Igoumenidis, 
Chlouverakis, and Vardas, 1998; Vardas, Kochiadakis, Orfanakis, Kalaitzakis, and 
Manios, 1994) while another study has shown repeatability of heart rate and blood 
pressure responses using lower body negative pressure to induce a physiological stress 
(Lightfoot, Hilton, and Fortney, 1991). However, there have been no published studies 
assessing the reproducibility of heart rate variability using lower body negative pressure. 
Statement of the Problem 
The tilt table test is a common method used to induce an orthostatic stress on patients 
in the clinical environment. LBNP is a tool use~ for inducing an orthostatic stress on 
individuals in a research environment. Heart rate variability responses are documented as 
being reproducible when assessed with the orthostatic stress of a tilt test. Hemodynamic 
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responses such as heart rate and blood pressure have also been shown to be reproducible 
using LBNP. However, there are no published data showing the reproducibility of heart 
rate variability responses using LBNP. Therefore, the. purpose of this study was to 
determine if spectral analyses of the heart rate variability responses to lower body negative 
pressure are reproducible. 
Research Hypothesis 
Ho: The heart rate, heart rate variability, and .spectral analysis values from two separate 
LBNP tests will be similar within subjects. 
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CHAPTER 2: REVIEW OF LITERATURE 
This review of literature examines the components of the cardiovascular system which 
are responsible for the compensatory effects to changes in blood pressure. Lower .body 
negative pressure testing is also discussed. The use of spectral analysis of heart rate 
variability as a tool for determining frequency d~ei-ences is examined. The final segment 
of this review examines the reproducibility of heart rate variability indices and the 
importance of further studies. 
Cardiovascular Control 
The cardiovascular system is an important organ system because of its role in 
circulating blood, lymph, and nutrients throughout the extremities of the body. The 
cardiovascular system is also responsible for maintaining the temperature in the body by 
changing the flow of the blood within the body. Because of the need for blood,-it is 
important to maintain adequate blood pressure to keep all the areas of the body 
appropriately perfused. Consequently, maintaining blood pressure homeostasis is a 
fundamental role of the cardiovascular control system. An-important component ofthis 
system is the baroreceptors. 
Baroreceptors are pressure-sensitive stretch receptors that help to maintain the blood 
pressure within the body. The baroreceptors are afferently connected to the medulla 
oblongata of the brain via the glossopharyngeal and vagus nerves. When these receptors 
are not stretched due to a decrease in blood pressure, there is a decrease in action 
potentials and a decrease in the inhibitory signals sent to the control centers of the medulla 
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oblongata. This results in an increase in sympathetic activity and a 1ecrease in 
parasympathetic nerve activity. The result is an increase in· heart rate and peripheral 
vasoconstriction that increases blood pressure (Fox, 1991), When the blood pressure is 
elevated, the receptors are stretched and the frequency of action potentials, sent to the 
cardiac control center, are increased. This increase in the inhibitory signals to.the control 
center causes a decrease in heart rate and an increased vasodilation (Fox, 1991). 
There are two types ofbaroreceptors: cardiopulmonary and arterial receptors. 
Cardiopulmonary baroreceptors are low-pressure receptors that are located within the 
atria and the lungs. These receptors are responsible for detecting changes in central 
venous pressure and central venous return. By this mechanism, forearm vascular 
resistance can be increased without significant changes in blood pressure, heart rate, or 
mean arterial pressure (Desai, Collins, Snell, and Mosqueda-Garcia, 1997). Lower body 
negative pressure testing has been used to determine the negative pressure that effectively 
decreased the blood pressure detected by the cardiopulmonary receptors. 
Cardiopulmonary baroreceptors are affected with graded LBNP from-5 to -20 mmHg 
(Johnson, Rowell, Niederberger, and Eisman, 1974). Zoller, Mark, Abboud, Schmid, and 
Reistad ( 1972) concluded that a lower body negative pressure of -10 mmHg could 
successfully unload .the cardiopulmonary baroreceptors without unloading the arterial 
receptors. This process results in a decrease in central blood volume and central venous 
pressure. This also causes an increase in vascular resistance without the_ significant 
increase in blood pressure or heart rate commonly observed during· arterial unloading 
(LaColley, Pannier, Slama, Cuche, Hoeks, Laurent, London, and Safar, 1992). 
7 
Cardiopulmonary receptors are also involved in the vasoconstrictor response to 
venous pooling (Zoller, 1972). Zoller and colleagues found vasoconstriction within the 
forearms.of the subjects during LBNP without any remarkable changes in the arterial 
pressure. Rowell, Wyss, and Brengelmann (1973) noted a contribution of both skin and 
muscle vascular beds to the compensatory vasoconstriction in the forearm during LBNP; 
50% of the decrease in total forearm blood flow is due to vasoconstriction in the skin. 
Arterial baroreceptors are high-pressure receptors that reside in the carotid sinus and 
aortic arch. These receptors are affected by a change in the systemic arterial pressure and 
carotid arterial pulse pressure. LBNP of-40mmHg decreases the amount ofblood at the 
carotid sinus baroreceptor and increases pooling of blood in the lower extremities which 
causes vasoconstriction of the splanchnic vessels, increased forearm resistance and 
tachycardia (Melchior, Srinivasan, Thullier, and Clere, 1994). Abboud, Eckberg, 
Johannsen, and Mark (1979) found a decrease in splanchnic blood flow during-40 mmHg 
accompanied with an increase in heart rate. This finding suggest that there is increased 
vascular resistance and an increase in heart rate when the arterial baroreceptors are 
unloaded. 
There is evidence of an interaction between the cardiopulmonary and carotid 
baroreceptors in cardiovascular hemodynamics. Victor and Mark (1985) demonstrated 
that an inhibitory interaction between cardiopulmonary and carotid baroreflex control of 
vascular resistance exists in humans. By selectively unloading the cardiopulmonary 
receptors with non-hypotensive LBNP and using neck pressure to stimulate the carotid 
baroreceptors, the vasoconstrictor response was sustained indicating an inhibition of the 
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carotid baroreflex by the cardiac vagal afferents. By removing this inhibition, during 
upright posture, the carotid baroreflex stimulates the reflex vasoconstriction (Victor et al., 
1985). Pawelczyk and Raven (1989) suggested that the reductions in central venous 
pressure and/or central blood volume augment heart rate and blood pressure by reducing 
an inhibitory influence from the cardiopulmonary receptors on the arterial baroreceptors. 
Spectral Analysis of Heart Rate Variability 
Heart rate variability refers to the beat-to-beat fluctuations in heart rate caused by the 
autonomic nervous system. These fluctuations are known to be caused when there is a 
change in the modulation of the efferent output of the parasympathetic or sympathetic 
nervous systems on the cardiovascular system (Pomeranz, 1985). When analyzed 
appropriately, these fluctuations in HRV can reveal various characteristics indicative of 
autonomic nervous system abnormalities. Another method of analyzing HRV, spectral 
analysis, has been used as a non-invasive technique for examining the functions of the 
autonomic nervous system. Spectral analysis has been useful in detecting sympathetic and 
parasympathetic failure (Luutonen, 1994) .. 
Spectral analysis ofHRV uses the time domain of the HRV signal and converts it to a 
frequency signal, producing a more coherent signal to be analyzed. The frequency signal 
read in the spectrum is typically between 0.01 to 0.50 Hz and is referred to as the total 
power spectrum. A power spectrum of 0 .15 to 0. 4 Hz is called the high frequency (HF) 
band spectrum and is associated with parasympathetic activity. The spectral reading 
between 0.01 to 0 .15 Hz is referred to as the low frequency band and is associated with 
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respiratory and sympathetic activity (Luutonen et al., 1994). There is still some 
uncertainty about the amount of sympathetic activity that occurs in the low-frequency 
spectral band (Pomeranz et al., 1985). Because of this uncertainty, a computation of the 
low-frequency/ high-frequency ratio (LF/HF ratio) has been used as an index of 
sympathovagal interaction (Luutonen et al., 1994) or sympathetic activity. Another 
spectral band, very low frequency (VLF) which is less than 0.01 Hz, is much less defined 
and does not have coherent properties. VLF assessed from short-term recordings are 
dubious and should be avoided when power spectral densities of short-term ECGs are 
interpreted (Task force, 1996). 
The influence of respiration has been an important factor frequently overlooked in the 
study ofHRV. Novak, P. Novak, De Champlain, Le Blanc, Martin, and Nadeau (1993) 
studied the effects of respiration on heart rate and blood pressures fluctuations. Sixteen 
subjects (14 males and 2 females) inhaled and exhaled in synchrony with a tone to regulate 
the frequency of breathing. The LF/HF ratio from a global spectra were elevated (P=0.05) 
over the non-respiratory/respiratory frequency content indexes; this leads to false positive 
global spectral indexes (Novak et al., 1993). Breath-to-breath slowing of respiration from 
0.46 to 0.05 Hz continuously paced the respiratory fluctuations in the R-:-R intensity, 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) over the entire period; 
this indic.ated the control of respiration frequency on the time-frequency distribution 
(Novak et al., 1993). Novak and colleagues (1993) concluded that respiration can 
override the hemodynamic fluctuations in both the time and frequency domains and the 
0.012 to 0.017 Hz rhythm reflects the brain stem network common to cardiovascular and 
· respiratory systems. 
Brown, Beightol, Koh, and Eckberg ( 1993) also studied the influence of respiration on 
R-R interval power spectra. Nine subjects were subjected to an array of breathing 
protocols at two tidal volumes (1,000 and 1,500 ml). They found a significant decrease in 
power at the respiratory frequency as the respiratory rate increased (P< 0.001). Major 
reductions occurred between the respiratory rates of0.125 to 0.25 Hz (7.5 -15 
breaths/minute) at both tidal volumes of 1,000 and 1,500 ml. They concluded that 
breathing frequencies strongly influence low-frequency power spectra and should be 
accounted or controlled for when evaluating HRV (Brown et al., 1993). 
Schmitz, Claus, Neundorfer, and Handwerker (1995) compared different algorithms 
for evaluating respiratory sinus arrhythmia using 11 subjects. They found, by regression 
analysis, that the heart rate increase is more closely coupled to inspiration than the heart 
rate decrease to expiration (Schmitz et al., 1995). 
Cooke, Cox, Diedrich, Taylor, Beightol, Ames, Hoag, Seidel, and Eckberg (1998) 
studied breathing protocols and cardiovascular rhythms and determined that the most 
efficient assessment can be made using a step-wise protocol without stringent control of 
inspired volume. Ten subjects followed 5 breathing protocols while R-R intervals and 
arterial pressure spectral power were measured. Control of inspired volume reduced R-R 
interval spectral power during 0.1 Hz breathing (P < 0.05). During stepwise breathing, 
the arterial pressure and the R-R interval spectral power increased as breathing frequency 
decreased. They concluded that a fixed and random-rate breathing protocol can decrease 
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CO2 chemoreceptor stimulation. They also noted that a stepwise protocol without 
stringent control of inspired volume allows for the most efficient assessment (Cooke et al, 
1998). Breathing at a frequency greater than 0.10 Hz does not influence low-frequency 
R-R interval or arterial pressure rhythms. 
Reproducibility 
Reproducibility of the HR V responses is important in identifying and interpreting true 
meaningful values for the spectral band readings. Such values allow clinicians to make 
inferential diagnoses of autonomic dysfunction such as predicting risk for sudden cardiac 
death. The reproducibility ofHRV measures were observed by Kleiger, Bigger, Bosner, 
Chung, Cook, Rolnitzky, Steinman, and_Fleiss (1991) using normal healthy subjects. 
Fourteen male subjects were studied for reproducibility of time and frequency domain 
measurements using 24-hour Holter monitoring. A Holter monitor is a portable ECG 
machine used to record ambulatory measurements. The baseline and placebo recordings · 
were reproducible, showing a correlation >O. 9 between the root mean square successive 
difference (r-MSSD), night/day difference (NDDift) and high frequency power. Low 
frequency power was correlated with r-MSSD (r = 0.9), the proportion of adjacent normal 
R-R intervals differing by> 50ms [pNN50 (r = 0.8)], and high frequency power (r = 0.9) 
indicating a strong dependency of low frequency power on vagal tone in these normal 
individuals (Kleiger et al., 1991). They concluded that intraclass correlation (r = 0. 8) as 
well as group measurements in normal subjects are remarkably stable (Kleiger et al., 
1991). 
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A repeatability experiment was performed by Cloarec-Blanchard, Funck-Brentano, 
Lipski, Jaillon, and Macquin-Mavier (1997) on healthy young male subjects using 
nitroglycerin (NTG) and 60° of head-up tilt to stimulate tachycardia. This study used 10 
volunteers aged 21-29 years for the nitroglycerin study and 13 volunteers aged 22-40 
years for the tilt table study. Volunteers for the NTG study were placed in a supine 
position with an indwelling catheter placed in the left antecubital vein. Sodium chloride 
(0.9%) was infused while baseline recordings were taken for 30 minutes. After baseline 
recordings were taken, 0.45mg ofNTG was infused in 1 minute and recordings were 
taken for 10 minutes. These subjects were brought back to the laboratory 24 hours later 
to repeat the protocol. 
For the head-up-tilt tests each subject was strapped onto a table tilt in a resting supine 
position for 30 minutes. After the rest period, each subject was brought to a tilt of 60° 
head up over a 20-second period and was left in this position for 10 minutes. The subjects 
returned 1 week later and repeated the protocol. They found no difference in heart rate or 
blood pressure between the two test days. The LF, HF, and LF /HF ratio spectral 
measures were reproducible. The LF component had a change of 438 +/- 98 for trial 1 
and 436 +/- 110 for trial 2. The LF/HF component had a change of2.84 +/- 0.50 for trial 
1 and 2.30 +/- 0.30 for trial 2. These changes were calculated as the difference of the 
values observed at 60 degrees of tilt minus the values observed at rest. The spectral 
components were found to be reproducible for both head-up tilt and nitroglycerin 
intervention (Cloarec-Blanchard et al., 1997). 
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Pardo, Merz, Paul-Labrador, Velasquez, Gottdiener, Kop, Krantz, Rozanski, and 
Peter ( 1996) studied the stability of heart rate variability in subjects with coronary artery 
disease (CAD). Thirty patients with stable CAD were studied using two consecutive 24 
hour Holter monitoring recordings. They had the subjects withhold any anti-ischemic 
medications or beta-blockers during the study. They found the correlation for HRV 
measures between days remained high (range 0.871 to 0.983; p < 0.0001) despite the 
stratification by the magnitude of daily_life ischemia (Pardo et al., 1996) 
Ponikowski, Piepoli,·Amadi, Chua, Harrington, Volterrani, Columbo, Mazzuero, 
Giordano, and Coats (1996) studied the reproducibility ofHRV in subjects with chronic 
heart failure (CHF). They did not use any medical intervention to stimulate tachycardia. 
Sixteen patients (mean age: 61 +/- 9 years) were used in the study. The subjects reported 
to the lab on two separate occasions for 60 minutes of recording time. The mean of all 
normal RR intervals (mean RR), standard deviation of all normal RR intervals (SDRR) 
and the percentage of adjacent normal RR intervals more than 50 ms different (pNN50) 
were calculated for the time-domain measures. Frequency domain was expressed in 
ms2/Hz. The reproducibility of time-domain and spectral readings were low compared to . . 
other studies. Reproducibility of spectral measures was very low for all of the indexes 
with a variation coefficient range of 45-111 %. They recalculated the values under log and 
square root transformations. Ponikowski and colleagues concluded that the 
reproducibility ofHRV in patients with moderate to severe CHF is low and recordings of 
20 minutes in stable, controlled conditions should be taken to optimize signal acquisition 
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in subjects with CHF so that very low frequency power can be studied (Ponikowsky et al., 
1996). 
Sloan, Shapiro, Bagiella, Gorman, and Bigger (1995)-used psychological challenge to 
stimulate tachycardia to study the stability of heart period variability. Subjects were 
exposed to a mental arithmetic task and a reaction time task within a 9-month period. The 
study found a reproducibility of low-frequency and total power measures but poor 
reproducibility of the high-frequency measures. This was believed to be different from 
other psychological studies because of the longevity of the experiment and the difference 
in methodology. 
Vardas and colleagues (1994) examined the intraindividual reproducibility ofHRV 
before and during a postural tilt in patients with syncope of unknown origin. Twenty 
patients with a history of syncope were tested and placed in two groups. Group A 
consisted of 11 patients who experienced syncope on one or both of the tilt tests. Group B 
consisted of 9 patients who did not experience any syncopal episodes during the tests. 
Spectral indexes (SI) were computed using the Fast Fourier analysis (FFT) of2-minute 
segments of Holter recordings. They found that the SI was reproducible between the two 
test trials (6.43 +/-0.97 vs 6.80 +/- 1.30; P=NS). 
Another study by Kochiadakis, Orfanakis, Rombola, Chrysostomakis, Chlouverakis, 
and Vardas (1997) examined the reproducibility of time-domain indexes ofHRV in 
patients _with vasovagal syncope. Nineteen patients with syncopal episodes were used as 
the experimental group and 15 healthy individuals were used as the control group. Each 
subject underwent a tilt table test on tw<? separate occasions to determine the differences 
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in time-domain indexes. The control group showed good reproducibility of all of the 
HRV indexes (slope of0.86 to 0.97) (K.ochiadakis et al., 1997). The syncope group 
showed significantly less reproducibility of the rMSSD measure( slope 0.78) and a lack of 
reproducibility of pNNSO (slope 0.52). The HR, standard deviation of 5-minute mean of 
all coupling intervals between normal beats (SDANN), _and standard deviation about the 
mean of all coupling intervals between normal beats (SDNN) were highly reproducible. 
The cause for this difference was due to the difference in HR V indexes between the group 
that had a negative second tilt test (P-~ group) and the group that had a positive second 
tilt test (P-P group). 
Another study by Kochiadakis and colleagues (1998) evaluated the reproducibility of 
tilt table testing in patients with vasovagal syncope and its relation to variations in 
autonomic nervous system activity. Thirty-five patients with vasovagal syncope 
underwent two tilt table tests to derive both time-domain.and :frequency domain indexes of 
HR V. Fifteen healthy volunteers also underwent the two tilt tests and served as the 
control group. The study reported HRV indexes between the patients that experienced 
syncope during both days of the tilt test (P-P), the group that experienced syncope during 
one of the days of testing (P-N) and the control group that showed no signs of syncope. 
The control group did not show any significant change in the mean LF /HF ratio between 
the two days (.01 +/- .05) and the P-P group also retained stable LF/HF values (0.002 +/-
_OS). The P-N group experienced a significant difference in the LH/HF ratio (0: 10 +/-
.06). The study concluded that patients with vasovagal ·syncope show variations in vagal 
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autonomic tone and these patients are prone to syncope during times when they have 
increased parasympathetic tone (Ko~hiadakis et al., 19~8). 
There are limited data on the stability ofHRV indexes induced by.lower body negative 
pressures (LBNP). Lightfoot and colleagues (1991) examined the repeatability of 
physiological factors, such as tolerance and heart rate~ usingLBNP instead of the tilt table. 
Four males and seven females were used for this study and the modified NASA LBNP 
protocol was implemented. Each subject was exposed to 4 LBNP tests with the 
exposures separated by 72 hours. They found similarity in the HR and, BP measures 
between the 4 LBNP tests. The mean difference in peak LBNP minus pre LBNP HR 
(MIR) was 37 +/- 4 bpm for the first and last test. The MIR for the second and third tests 
were 45 +/- 5 bpm and 46 +/- 4 bpm (p = 0.31 ). The meap. differences in peak LBNP 
minus pre LBNP systolic blood pressure (~SBP) for_the first and second test were-19 +/-
2 mmHg and -24 +/- 2 mmHg. The ~SBP for the third and last tests were -22 +/- 3 
mmHg and-22 +/- 4 mmHg (p = .70). The ADBP was -1 +/- 2 mmHg for the all the 
LBNP tests. The.correlation coefficients of the repeated tests were between 0.64 to 0.71. 
These results concluded that HR and BP measures are reproducible. 
To date, many studies have been done to show-the uses of heart rate variability in the 
clinical setting. Such studies involved resting undisturbed HR V measures as well as HR V 
measures perturbed by the induction of a stress. Most of these studies have been repeated 
to confirm the stability ofHRV measures. The tilt test has been performed and spectral 
components have been reproduced. However, the question still remains unanswered: are 
spectral components ofHRV during LBNP reproducible? LBNP is a direct means of 
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stimulating orthostatic stress and is commonly used in the experimental environment. 
Subjects under the LBNP testing protocol reach a definite ending point and this allows for 
a more accurate assessment of autonomic function. There are no published studies 
assessing the reproducibility ofHRV during LBNP. This area of research is still fertile 
and needs to be explored in order to use HR V as a tool for accurate assessment of the 
ANS. 
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CHAPTER 3: METHODS 
General Experiment Design 
Sixteen college age students were used for this experiment. Subjects with previous 
vasovagal reactions were not included. All subjects were made aware of the risks and 
benefits of the experiment and provided written informed consent prior to data collection. 
Subjects came to the lab three times: once for orientation and twice for LBNP tolerance 
tests. Each subject completed a questionnaire to estimate physical activity and V02 max 
(George, Stone, and Burkett, 1996). Height and weight were recorded and body 
composition was estimated from the sum of three skinfold thickness readings (Jackson and 
Pollock, 1985). 
The lower body negative pressure chamber was used to_ induce orthostatic stress. An 
automated· sphygmomanometer was used to monitor blood pressure and an 
electrocardiograph (ECG) was used to monitor heart rate. The ECG data were used to 
perform the spectral analysis of heart rate variability. Forearm blood flow was measured 
every 20 seconds using a venous occlusion plethysmograph while cardiac output was 
determined using impedance cardiography. Breathing was controlled by a timed breathing 
protocol using a clock. 
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Orientation Session 
Each subject reported to the Hemodynamics Laboratory one week before the first 
LBNP test to become acquainted with the breathing protocol and the LBNP chamber. 
After verbal explanation of the procedure to be used, the subject was placed into the 
LBNP testing chamber in the supine position. The LBNP testing chamber was not 
activated. Each subject had a laboratory timer placed within view so the display could be 
easily seen. The display had the time (in seconds) marked with a white and red marker. 
Each subject inhaled each time the second hand reached a white marker and exhaled when 
it approaches the red marker. The clock provided a consistent breathing pattern for all the 
subjects and prevented respiration-related disturbances in cardiac rhythms. Each subject 
breathed at a frequency of0.2 Hz (12 respirations per minute) for 6 minutes with no 
negative pressure imposed (0 mmHg). After completing this timed procedure, the subject 
was exposed to graded LBNP. The subject underwent decreases in LBNP of -10 mmHg 
for 2 minute durations up to a maximum of -50 mmHg. The subject continued to breathe 
at the prescribed rate. This protocol was done 1 week before the true LBNP trials were 
performed.-
LBNP Testing. 
Each subject reported to the Hemodynamics Laboratory and was instrumented for 
stroke volume, ECG, and forearm blood flow measurements before assuming the supine 
position inside the LBNP testing chamber. Once they were inside the chamber, they were 
sealed at the waist and told to relax for 15 minutes at ambient barometric pressure (0 
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mmHg). This allowed time for the subject to achieve a homeostatic state_. Each subject's 
breathing frequency was controlled in the aforementioned manner. 
The LBNP test consisted of graded LBNP to -100 mmHg, presyncopal symptoms or 
by su~ject request. LBNP was increased in 10 mmHg increments every 6 minutes. LBNP 
was monitored using an electronic barometer. Symptoms of impending presyncope 
include dizziness, nausea, profuse sweating or a change in blood pressure ( decrease in 
SBP by 25mmHg or a decrease in DBP by 15mmHg within 1 minute). Each subject was 
monitored for presyncopal symptoms by close observation and questions directed toward 
the physical condition during each stage._ Each.subject inspired and expired at the 
appropriate time points as indicated by the markings throughout the test. The cumulative 
stress index (CSI) was calculated as the sum.of pressures achiev~d times the amount of 
time at each pressure. This protocol was repeated one week later. · 
All subjects.were aske~ to.refi:ain froni any exercise, alcohol, and caffeine ingestion 12 
hours before their LBNP testing and from any food 3 hours before testing. 
Assessment of Cardiovascular Respo~ses 
Forearm blood flow was measured using mercury-in-silastic strain gauge 
plethysmography (D. E. Hokanson, Bellvue, WA; Whitney, 1953). The left forearm was 
elevated with the wrist suspended slightly higher. The strain gauge was placed around the 
proximal portion of the forearm about 011:e-third the distance from the olecranon to the 
ulna styloid and a blood pressure cuff was placed around the biceps. A wrist cuff was also 
used to occlude circulation to the hand during FBF measurements. The cuff around the 
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bicep was inflated to 45 mmHg for 10 seconds and was released for 10 seconds. Forearm 
blood flow was consequently assessed every 20 seconds. 
Blood pressure was assessed continuously using a finger photoplethysmograph 
(Finepres, Critikon, Tampa, FL) on the upper right arm. Heart rate was assessed using 
standard electrocardiography (ECG) and 5 electrodes. Stroke volume was determined 
every 30 seconds using a Minnesota Impedance Cardiograph (Model 304B, Surcom, 
Minneapolis, MN). Two band electrodes were placed around the subject's neck and chest 
and ECG electrodes were placed on the forehead and the abdomen. This tetrapolar lead 
configuration has been validated (Gotshall and Sexson, 1994). The analog heart rate, 
blood pressure, forearm blood flow and LBNP level signal were relayed into an on-line 
microcomputer system using commercially available software (BIOPAC). The heart rate 
and impedance cardiograph signals were also analyzed using commercially available 
software (Microtronics Corp) to determine stroke volume and calculate cardiac output. 
Heart Rate Variability Analysis 
The analog heart rate signal was entered into a personal computer using an analog to 
digital converter. Amplification and anti-aliasing filters were used to ensure accurate data 
digitization from problems arising due to poor signal-to-noise ratios. R waves were 
detected and processed with an algorithm using the modified threshold method. The 
power spectrum was calculated using the Welch's averaged periodogram method. The 
last 256 R-R intervals of the rest period and the last 256 intervals of each level ofLBNP 
were used in the power spectrum calculation. Total power (TP) for each subject was 
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defined as the area under the HR V spectrum. The HR V spectrum was between the 
frequencies of 0.0001 to 0.5 Hz. The magnitude of the low frequency (LF) component of 
the spectrum was based on the spectral amplitudes between O. 04 to O .15 Hz and the high 
frequency (HF) component was set at 0.15 to 0.40 Hz (Task Force, 1996). The LF/HF 
ratio was calculated to serve as an indicator of sympathetic nervous system activation. 
Normalization represents the·relative·value ofLF and HF in proportion to the total power 
minus the very-low frequency (VLF) component (Task Force, 1996). Normalized units of 
spectral components were reported to reduce the elf ect of the change~ in total power on 
the values ofLF and HF and it also emphasizes the controlled and balanced behavior of 
the autonomic nervous system (Task Force, 1996). 
Statistical Analysis 
Mean cardiovascular responses for t~e minutes 2-6 of each stage of LBNP common 
to all subjects were determined. If the subject did not complete a stage ofLBNP, the 
-minutes of the final stage ( excluding the first minute) that was tolerated by the subject 
were used for data analysis. Cardiac output (Q) was calculated every 30 seconds using 
the stroke volume (SV), which was assessed by the impedance cardiograph, and the 
concurrent HR (CO= SV * ·HR). Pulse pressure was calculated as the diastolic blood 
pressure (DBP) subtracted from the systolic blood pressure (SBP). Mean arterial pressure 
(MAP) was calculated as the sum ofDBP and 1/3 pulse pressure. Forearm vascular 
conductance (FVC) was calculated as forearm blood flow (FBF)IMAP. Total peripheral 
conductance (TPC) was calculated as Q/MAP. Cronbach' s alpha was determined for each 
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variable at each stage to assess reliability. Statistical significance was set at p < 0.05 and 
data were presented as means ± SEM. 
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CHAPTER4:RESULTS 
Response to LBNP 
Sixteen subjects completed both trials of LBNP testing. Data for l subject were 
excluded because of ectopic beats. Table 1 summarizes the physical characteristics of the 
subjects (n=15). 
Table 1- Anthropometric data for all subjects (n=15). BMI, body mass index. 
Age (years) 
Height (cm) 
Weight (kg) 
BMI (kg/m2) 
Percent fat (%) 
Estimated VO2(ml/kg/min) 
23".6±3.0 
69.4±2.4 
83.1±17.1 
26.7±4.9 
10.7±3.6 
50.4±6.3 
The cumulative stress index (CSI) was 1586 ± 622 for trial 1 and 1864 ± 605 for trial 
2 (P<0.05). LTI was 400 ± 81 and 438 ± 77 for trials 1 and 2, respectively (p<0.05). 
These values equate to the subjects tolerating 4 minutes of -60 mmHg in trial I and 2 
minutes of - 70 mmHg in trial 2. 
The qualitative car?iovascular r~spon_ses were similar for_ all t~e subjects in both trials. 
Because of the differing s~ages at which people became presyncopal, data on 15 subjects 
were plotted through -60 mmHg. Seven subjects were plotted at - 70 mmHg and 3 
.•- . 
subjects were plotted at -80 mmHg. Heart rate increa_sed for all of the subjects as the 
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level ofLBNP increased (Figure 1). Cardiac output decreased as the level ofLBNP 
increased (Figure 2). The mean arterial pressure was maintained throughout the protocol 
for all subjects (Figure 3). Forearm vascular conductance and total peripheral conductance 
decreased slightly throughout the LBNP protocol (Figures 4 and 5). Using qualitative 
analyses (means+/- SEM) there were no changes in the cardiovascular responses observed 
between trials. 
High frequency (HF) values ofHRV decreased with increased negative pressure 
(Figure 6). Low frequency (LF) values ofHRV remained constant throughout the LBNP 
protocol (Figure 7). HF, in normalized units (Hfnu) also decreased throughout the LBNP 
protocol (Figure 8). LF in normalized units (Lfnu) increased during the LBNP protocol 
(Figure 9). The LF/HF ratio values increased throughout the LBNP protocol (Figure 10). 
Total power values decreased with increased negative pressure (Figure 11 ). 
Reliability of LBNP Testing · · 
Table 2 summarizes the Chronbach's alpha values for reliability of each stage of 
LBNP. Heart rate'(HR) showed consistently high reliability (a> .70) for each stage of 
LBNP. High frequency in normalized units (Hfnu) and low frequency in the normalized 
units (Lfnu) were all greater than 0.7 for each stage ofLBNP with the exception of the 
resting stage (0mmHg). E-1 and E are not reported for the spectral data.because spectral 
data can't be determined for these short (1 minute) durations. 
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Table 2- Chronbach's Alpha values for intraclass reliability (n=14). 
0 -10 -20 -30 -40 -50 -60 E-1 E 
Lfabs .81 .91 .54 .71 .81 .60 .68 -- --
Lfnu .43 .78 .77 .84 .80 .78 .19 -- --
Hfabs .93 .80 .81 .49 .90 .82 .70 -- --
Hfnu .41 .77 .78 .84 .80 .84 .47 -- --
LF/HF " .19 .69 .78 .61 .56 .42 .36 -- --
Tot power .90 .87 .60 .54 .74 .68 .51 -- --
HR .87 .89 .88 .87 .88 .93 .92 .88 .68 
co .65 .79 .69 .88 .37 .56 .51 .33 .44 
sv .85 .82 .85 .88 .56 .83 .44 .52 .31 
FBF .77 .74 .70 .66 .58 .61 .37 -.27 .66 
FVC .58 .65 .60 .45 .49 .60 .21 -.60 .26 
TPC .54 .59 .50 .58 .47 .42 .44 .14 .24 
SBP .04 .35 .68 -.43 .16 -.11 .48 -.13 .50 
DBP -.45 .41 .60 -.19 .12 .64 .19 -.71 .60 
MAP -.50 .35 .47 -.08 .16 .01 .23 -.75 .48 
pp .51 .41 .35 -.46 .29 -.32 .63 .51 .44 
E-1: next to last minute of the final stage ofLBNP achieved. E: last minute ofLBNP 
achieved. · ·· 
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Figure 1. Heart rate responses to lower body negative 
pressure. 
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Figure 2. Cardiac output responses to lower body negative 
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Figure 4. Forearm vascular conductance responses to lower 
~ody negative pressure. 
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Figure 5. Total peripheral conductance.response to 
lower body negative pressure. 
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Figure 7. Low frequency spectral response to lower 
body negative pressure. 
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Figure 9. Low frequency (in normalized units) response 
toLBNP. 
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Figure 10. Low :frequency to high :frequency ratio to lower 
body negative pressure. 
-80 
0.006 
,_ 
d= 0.004 _, 
I-< 
s: 
0 
0.. 
..... . 0.002 0 
t'"" 
0.000 
0 
37 
-20 -40 -60 -80 
Lower body negative pressure (mmHg) 
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CHAPTER 5: DISCUSSION 
Reproducibility of heart rate variability, the beat-to-beat temporal fluctuations of the 
heart, has been previously assessed using the technique of the table tilt test. In these 
studies, the cardiovascular responses (heart rate, cardiac output, mean arterial pressure) to 
LBNP have also been examined for reproducibility. In this study, reproducibility of heart 
rate variability was examined using lower body negative pressure(LBNP). For 
comparison, reproducibility of the cardiovascular responses were also examined. 
The results of this study show that spectral components of heart rate are reproducible 
in males during LBNP to tolerance. The qualitative response of HF, LF, and total power 
were identical in the test-retest protocol. The Chronbachs alpha data for HRV shows a 
good correlation (a> 0.7) for LF and HF spectral components. No other similar studies 
have been published using LBNP as the technique for inducing an orthostatic stress. The 
subjects exhibited reproducibility of hemodynamic responses to the LBNP tests similar to 
that seen by others (Lightfoot et al., 1991). 
Vardas and colleagues (1994) obtained results similar to the present study. Twenty 
patients with a history of syncope participated in two table tilt tests 1 to 6 weeks apart. 
Subjects were grouped according to the results of the test: Group A for subjects who had 
a positive test for 1 or both trial and Group B for the subjects that with 2 negative tests. In 
both groups, there was no significant difference in the spectral index for HF, LF and total 
power. Postural tilt test was performed in their study on a population with syncopal 
episodes. The current study involved the use ofLBNP to induce the orthostatic stress and 
used a healthy population. 
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Sloan and colleagues (1995) demonstrated reproducibility ofHRV using psychological 
challenges such as arithmetic and reaction time tasks to inquces changes in cardiovascular 
activity. They reported an intraclass correlation coefficient (ICC) of 0 .17 to 0. 73 for HR 
and HF power. The investigators noted that the length of the experiment had some 
influence over their results. The present study, however, reported Chronbach's alpha 
coefficients between 0.87 to 0.93 and between 0.49 to 0.93 for HR and HF, respectively. 
The LF /HF ratio data of the present study exhibited the stable features reported by 
Kochiadakis and colleagues (1998). Table tilt tests were used on 35 subjects with vaso-
vagal syncope and 15 healthy volunteers. The· spectral data from the subjects that 
completed both tests without syncope and the subjects that showed signs of syncope for 
both trials had reproducible LF/HF values. This was similar to the present study with the 
exception of the decrease in the LF/HF values for the subjects that demonstrated 2 
positive tilt tests. The decrease in LF /HF values was due to the increase in 
parasympathetic activity creating the syncopal episode for those subjects. The present 
study used healthy subjects with no. va.so-vagal syncope. Alpha coefficients were also 
computed; the reliability of the spectral indexes at each stage of LB NP for both trials were 
recorded. 
Pardo and colleagues ( 1996) assessed HR V in patients with myocardial ischemia while 
ambulatory for two 24-hour periods. Holter monitors were used to record the heart rate 
and were worn throughout the experiment. They used intraclass correlation coefficients to 
assess the correlation between the two 24-hour periods. They reported very high intra-
observer reproducibility ofHRV measures with ICC ranging from 0.990 to 0.999 
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(p<0.0001). The present study observed the intraclass correlation ofHRV on healthy 
subjects with no history of ischemia. LBNP was also used as a method of inducing an 
orthostatic stress. 
Lightfoot and colleagues (1991) examined the reproducibility of the cardiovascular 
responses to LBNP testing. Eleven subjects were exposed to 4 trails ofLBNP with 72 
hours of separation between each exposure. The subjects tested in their study had similar 
HR and change in systolic and· distolic blood pressures between the 4 trials. They assessed 
the test-retest data using repeated measures ANOV A There were no data presented for 
the reproducibility of either cardiac output or for the spectral components ofHRV. The 
present study reports reproducibility in HR and MAP. Cardiac output showed a similar 
descending pattern in both trials, indicating reproducibility of cardiac output. The present 
study also reported decreases in the forearm vascular conductance and total peripheral 
conductance responses and. reported reproducibility for these responses. The responses of 
the FVC and TPC are indicators of reproducible autonomic responses to an orthostatic 
stress. Spectral components (LF, HF, and LF/HF) were also analyzed in the present study 
and all values were assessed· for intra-class correlation using the Cronbach reliability test. 
The results of the current experiment demonstrate reproducibility of both 
cardiovascular and spectral component responses to LBNP. Heart rate for both trials 
increased while cardiac output decreased for both trials during the LBNP protocol. This 
increase in heart rate was due to an increased baroreceptor activation. HF spectral 
components decrease due to the decrease in parasympathetic activity. LF/HF ratio also 
increased during the LBNP protocol. 
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In summary, college-age men were able to increase heart rate during the LBNP 
exposures and decrease the HF spectral component of heart rate. These results were 
replicated within each subject during the second LBNP test. From the results of this study 
it can be concluded that spectral components of heart rate can be reproduced using LBNP. 
Recommendations for Future Research 
The subjects in the current study were moderately physically active. Comparing the 
reproducibility ofHRV for subjects with low physical activity to subjects with high 
physical activity may uncover differences in the response of autonomic activity between 
subjects. The current study examined the reproducibility within individual subjects. The 
present study did not examine the effects of catecholamines during LBNP. It may be 
possible for catecholamines to build up to different levels for each trial. Testing the level 
of catecholamines in the blood for each trial ofLBNP could uncover more secrets to the 
inner-workings of the cardiovascular system. Demonstrating reproducibility ofHRV 
values can increase the integrity of spectral analysis as a tool in the clinical environment. 
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